🔍
This $3 Penny Stock Just EXPLODED +747% 🔥 2 Penny Stocks Set To EXPLODE 🗣 Woooo!!! 🏆🚀 - YouTube
Channel: Corns Investing
[0]
What’s up everyone, we have recently seen
this $3 penny stock, Neurometrix (NURO) explode
[6]
by over 180% in the last trading day alone
and over 750% in the last 5 days on the back
[13]
of FDA approval.
[15]
And what’s interesting is that Neuro is
still only $95m in market cap.
[21]
NeuroMetrix Received FDA approval for their
Breakthrough Device, Quell Designated for
[28]
Treatment of Fibromyalgia, with its Wearable
Neurostimulation Technology.
[33]
Fibromyalgia is a common form of chronic pain
that is also accompanied by fatigue, sleep,
[39]
cognitive and mood disturbances which has
been huge on the back of covid lockdown stay
[45]
at home lifestyle.
[47]
It affects 5 million to 15 million people,
or 2% to 6% of the U.S. population, and is
[51]
most often diagnosed in people between the
ages of 30 and 50.
[58]
Quell is a non-invasive wearable neurostimulator
that provides flexible and precise nerve stimulation.
[65]
So in today’s video, I’ll be sharing with
you two solid biotech stocks with game changing
[70]
technology which are highly rated by analysts
and have FDA approval within sight.
[76]
These top penny stocks are risky bets which
haven’t been discovered by the market yet
[81]
and so have the potential to make you some
massive returns.
[84]
So make sure you don’t miss out on these
big bangers by liking the video and turn on
[90]
the notification bell to get these hot penny
stocks instantly.
[94]
And also if you want two free stocks worth
over $1800 from Webull and also where you
[99]
can buy fractional shares, please hit the
link in the top comment or description below.
[103]
I would really appreciate it.
[104]
Thank you so much.
[106]
So let’s get straight into it, with our
number 2 penny stock here, which is Inspira
[111]
Technologies Oxy (IINN).
[116]
It has a share price sitting at $4.81 and
market cap of $36.9m.
[121]
This penny stock is newly listed, so hasn’t
been discovered by the market yet.
[127]
It is up 6.6% over the last 5 days and flat
on the month.
[133]
Inspira is Nasdaq Listed with an average of
594k shares traded over a 30day period and
[141]
over 7.8mm shares outstanding, of which 33.8%
of the shares are held by insiders, so very
[149]
tightly held shares on this newly listed penny
stock.
[152]
Inspira Technologies, is an innovative Medical
Technology Company focused on the acute respiratory
[158]
care market.
[160]
The ART, Inspira’s novel technology, can
address the unmet need of providing acute
[166]
respiratory treatment that prevents mechanical
ventilation while patients are awake and breathing
[171]
spontaneously.
[173]
Based on sub-dynamic technology, the ART system
oxygenates 1 liter of blood in a minute, within
[179]
which the patient’s oxygen saturation is
boosted to a safe level of 95% or higher.
[186]
The affordability and simplicity of ART’s
respiratory treatment caters to millions of
[191]
people worldwide who currently do not have
access to Intensive Care Units.
[197]
The ART500 Technology is a unique alternative
which has significant advantages including
[203]
patient experience, cost advantage and ease
of use.
[207]
They have the Potential to lead the Early
Oxygenation Market With Multiple Growth Drivers.
[213]
The respiratory care market size is estimated
to reach approximately $29.86Bn by 2025.
[222]
And they have the opportunity to gain significant
market share from the established players
[226]
such as Philips, Siemens and more, with ~20
million patients annually admitted to ICUs,
[232]
requiring acute respiratory care.
[235]
So really exciting stuff.
[237]
They are taking a multi-step approach to the
regulatory clearance process, where they are
[243]
looking to submit the first 510(K) in Q4-2021
relating to primary sources of the ART500
[250]
with additional 510(k) filings planned for
2022.
[254]
And Additional milestones are planned for
2022 and 2023..
[259]
These milestones may seem a long way off but
they have a clear plan to create strategic
[263]
partnerships, collaboration with medical device
companies and strategic manufacturing agreements
[269]
which are multiple catalysts to blow its share
price if all goes to plan.
[275]
There are also other risks to be aware of
that, this stock will not be revenue generating
[279]
till ART500 is commercialised so until then
it will be incurring R&D costs and operating
[286]
expenses.
[287]
So a key watch out with this stock.
[290]
Next up to our number 1 penny stock here,
which is Electromedical Technologies Inc (EMED).
[297]
It has a share price sitting at 5.6cents and
market cap of $2.88m.
[302]
So a very very tiny stock but with massive
potential if you can stomach the risks with
[309]
this one.
[310]
This penny stock is down 19.8% over the last
month and over the last 6months it is down
[316]
87.5% making it feel like the only way is
down but the turnaround could be explosive
[323]
with its outlook and key milestones.
[326]
Electromedical is OTC QB Listed with an average
of 661k shares traded over a 30day period
[334]
and over 48.7m shares outstanding.
[338]
Electromedical is a bioelectronics manufacturing
company and their mission is to improve global
[344]
wellness for people suffering from various
painful conditions by relieving chronic and
[349]
acute pain using energy, frequency and vibration
as an alternative to pharmaceuticals.
[355]
They do this by delivering innovative solutions,
providing fast and long lasting pain relief,
[363]
across the broadest range of ailments and
engineer simple-to-use bioelectronics therapy
[368]
devices, which send a proprietary sequence
of electrical signals.
[373]
So very similar area of focus to Neurometrix
on chronic pain.
[378]
An analyst Rob Goldman recently covered this
penny stock in March at 30cents and gave it
[383]
a price target of $5.7 over a 12 – 18months
period.
[387]
3 months in, this penny stock is changing
hands at 5.6 cents meaning a potential upside
[394]
opportunity of 100X from current levels which
is extremely exciting.
[400]
And Here’s why.
[401]
They say EMED has achieved a key funding milestone
which they believe de-risks the stock and
[407]
affirms their revenue forecasts and price
target.
[411]
This leading, chronic pain management bioelectronics
provider boasts an FDA-cleared flagship device
[417]
that has a 10,000 unit installed base.
[420]
Plus, EMED is set for clearance of a new device
in early 2022 that is smaller, cheaper, and
[428]
with more capabilities including a telemedicine
feature.
[433]
Targeting multiple markets, EMED’s current
and future offerings are primed to serve as
[438]
an effective, and non-invasive alternative
to current drugs, including the $24 billion
[445]
opioids market.
[447]
Bioelectronics is an important and developing
field of “electronic” medicine which uses
[451]
safe electrical impulses over the body’s
neural circuitry to relieve pain, without
[457]
drugs.
[458]
And EMED’s innovative, affordable financial
model also includes a novel telemedicine feature
[463]
which, along with efficacy and ease of use,
should drive new adoption.
[468]
EMED’s recurring model includes a nominal
down payment and a monthly subscription fee.
[474]
Their forecasts include a conservative 80,000
POD units sold in 2022 and a 50% top-line
[481]
jump in 2023.
[484]
With an updated 12-18-month term and price
target of $5.70, EMED’s shares are undervalued,
[490]
relative to its peer group.
[493]
And in their view, the recent drop in stock
price from their initiation date represents
[498]
a terrific entry point for opportunistic investors.
[502]
So really exciting stuff and an explosive
outlook if this company can sell sell and
[507]
sell enough of this FDA approved WellnessPro
Plus products.
[513]
So a very interesting and mindblowing prospects
ahead for these penny stocks but only consider
[517]
getting in if the price is right for you and
if you fully understand the risks.
[521]
This video is not financial advice, a buy
or a sell recommendation, but is meant to
[526]
bring some new and exciting penny stocks to
your attention for you to do your own research..
[531]
As always I would love to hear from you, so
please let me know your thoughts on these
[535]
top penny stocks in the comments section below
and what other penny stocks are catching your
[539]
eyes lately.
[540]
And If you are new to my channel please ensure
to subscribe and hit the bell so you are notified
[545]
when I upload new videos.
[548]
If you would like to see more videos like
this, please check out this video right here
[552]
or this playlist right here to watch equally
insightful content from the channel.
[556]
Thank you so much for being here and I look
forward to have you in my next video.
[560]
Thank you
Most Recent Videos:
You can go back to the homepage right here: Homepage